Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADS-8902 (TCAD) vs Oseltamivir in Immunocompromised Influenza A
NCT00979251Phase 2Completed
- Start
- Sep 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of ADS-8902 in Influenza A (IAV). Started Sep 2009; status: completed.
02
Drugs
ADS-8902
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT00979251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00979251.